Influence of temperature on thromboelastometry and platelet aggregation in cardiac arrest patients undergoing targeted temperature management

Table 2 Antithrombotic medication

	Prior to cardiac arrest	On hypothermia^a	On normothermia^a
Medication, all/n (%)	40 (100)	40 (100)	37 (100)
Adenosine diphosphate receptor inhibitor, all:	3 (8)	19 (48)	16 (43)
Ticagrelor	2 (5)	14 (35)	14 (38)
Clopidogrel	1 (3)	6 (15)	2 (5)
Aspirin	15 (38)	29 (73)	25 (68)
Bivalirudin^b	0 (0)	12 (30)	0 (0)
Low molecular-weight heparin	0 (0)	28 (70)	29 (78)
Unfractionated heparin	0 (0)	19 (48)	0 (0)
Warfarin	3 (8)	0 (0)	1 (3)

Characteristics of 40 patients treated with targeted temperature management after cardiac arrest. Results are presented as number of patients (%), or median (range)
^aMedication given 24 hours prior to blood sample collection
^bUse of bivalirudin ended 16–20 hours before obtaining the hypothermic blood sample.

ISSN: 1364-8535